Pharmacogenetics as alien science : Alzheimer's disease, core sets and expectations

作者: Adam Hedgecoe

DOI: 10.1177/0306312706059746

关键词:

摘要: This paper takes Harry Collins’ concept of the ’core set’ and combines it with emerging work in sociology sociotechnical expectations to explore continued citation review papers a research result that is widely rejected by experts. The question, putative pharmacogenetic link between carrying APOE4 allele reduced response anti-Alzheimer’s disease (AD) drug Tacrine, was first reported 1995. Since then has been cited, helping create about pharmacogenetics or ’personalized medicine’. To majority clinicians researchers specialized AD (the core set) this little value – both scientifically defunct ethically risky although some supporters continue suggest masked commercial interests. shows how as an example leads commentators outside set ignore its controversial qualities use resource for expectation-building, but process producing representation resembles ’alien science’ (an inaccurate picture outsider conveys scientific topic based on literature, rather than interviews scientists involved).

参考文章(99)
Gary Edmond, The Law-Set: The Legal-Scientific Production of Medical Propriety: Science, Technology, & Human Values. ,vol. 26, pp. 191- 226 ,(2001) , 10.1177/016224390102600204
Harry M. Collins, Expertise: Between the Scylla of certainty and the new age charybdis Accountability in Research. ,vol. 5, pp. 127- 135 ,(1997) , 10.1080/08989629708573904
Laurent Bracco, Pharmacogenomics and Personalised Medicine Pharmacogenomics. ,vol. 3, pp. 166- 177 ,(2002) , 10.1517/14622416.3.2.166
Kathryn A. Phillips, David L. Veenstra, Eyal Oren, Jane K. Lee, Wolfgang Sadee, Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions JAMA. ,vol. 286, pp. 2270- 2279 ,(2001) , 10.1001/JAMA.286.18.2270
B. Winblad, K. Engedal, H. Soininen, F. Verhey, G. Waldemar, A. Wimo, A.-L. Wetterholm, R. Zhang, A. Haglund, P. Subbiah, , A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD Neurology. ,vol. 57, pp. 489- 495 ,(2001) , 10.1212/WNL.57.3.489
A. M. Saunders, W. J. Strittmatter, D. Schmechel, P. H. St. George-Hyslop, M. A. Pericak-Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, D. R. Crapper-MacLachlan, M. J. Alberts, C. Hulette, B. Crain, D. Goldgaber, A. D. Roses, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. ,vol. 43, pp. 1467- 1472 ,(1993) , 10.1212/WNL.43.8.1467
Nik Brown, Mike Michael, A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects Technology Analysis & Strategic Management. ,vol. 15, pp. 3- 18 ,(2003) , 10.1080/0953732032000046024
Julie A Johnson, William E Evans, Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity Trends in Molecular Medicine. ,vol. 8, pp. 300- 305 ,(2002) , 10.1016/S1471-4914(02)02354-7
Elizabeth C Jazwinska, Exploiting human genetic variation in drug discovery and development. Drug Discovery Today. ,vol. 6, pp. 198- 205 ,(2001) , 10.1016/S1359-6446(00)01642-1
Klaus Lindpaintner, Elizabeth Foot, Mark Caulfield, Ian Hall, Pharmacogenetics: focus on pharmacodynamics International Journal of Pharmaceutical Medicine. ,vol. 15, pp. 74- 82 ,(2001) , 10.1097/00124363-200104000-00009